Welcome to LookChem.com Sign In|Join Free

CAS

  • or

681853-92-9

Post Buying Request

681853-92-9 Suppliers

Recommended suppliersmore

  • Product
  • FOB Price
  • Min.Order
  • Supply Ability
  • Supplier
  • Contact Supplier
  • SAGECHEM/(3aS,4R,6aS)-4-((tert-butyldiphenylsilyloxy)methyl)-2,2-dimethyl-4,6a-dihydro-3aH-cyclopenta[d][1,3]dioxol-4-ol/SAGECHEM/Manufacturer in China

    Cas No: 681853-92-9

  • No Data

  • No Data

  • No Data

  • SAGECHEM LIMITED
  • Contact Supplier

681853-92-9 Usage

Description

(1R,4S,5S)-(+)-4,5-isopropylidenedioxy-1-(tert-butyldiphenylsilyloxymethyl)-2-cyclopenten-1-ol is a complex organic molecule characterized by a cyclopentenol backbone and multiple functional groups. It is defined by its specific stereochemistry, indicated by the (1R,4S,5S) configuration, and features isopropylidene and tert-butyldiphenylsilyloxymethyl moieties. This unique structure and the presence of various functional groups suggest potential applications in organic synthesis, medicinal chemistry, and as a chiral building block.

Uses

Used in Organic Synthesis:
(1R,4S,5S)-(+)-4,5-isopropylidenedioxy-1-(tert-butyldiphenylsilyloxymethyl)-2-cyclopenten-1-ol is used as a chiral building block for the synthesis of complex organic compounds. Its unique structure and functional groups allow for versatile reactions and the creation of a wide range of molecules with potential applications in various industries.
Used in Medicinal Chemistry:
In the field of medicinal chemistry, (1R,4S,5S)-(+)-4,5-isopropylidenedioxy-1-(tert-butyldiphenylsilyloxymethyl)-2-cyclopenten-1-ol is utilized as a key intermediate in the development of pharmaceutical compounds. Its specific stereochemistry and functional groups can be leveraged to design and synthesize novel drugs with improved efficacy and selectivity.
Used in Pharmaceutical Industry:
(1R,4S,5S)-(+)-4,5-isopropylidenedioxy-1-(tert-butyldiphenylsilyloxymethyl)-2-cyclopenten-1-ol is used as a precursor in the synthesis of pharmaceutical compounds. Its unique structure and functional groups make it a valuable asset in the development of new drugs, potentially leading to breakthroughs in the treatment of various diseases and conditions.
Further study and characterization of this compound's properties and reactivity are necessary to fully understand and exploit its potential for various chemical and pharmaceutical applications.

Check Digit Verification of cas no

The CAS Registry Mumber 681853-92-9 includes 9 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 6 digits, 6,8,1,8,5 and 3 respectively; the second part has 2 digits, 9 and 2 respectively.
Calculate Digit Verification of CAS Registry Number 681853-92:
(8*6)+(7*8)+(6*1)+(5*8)+(4*5)+(3*3)+(2*9)+(1*2)=199
199 % 10 = 9
So 681853-92-9 is a valid CAS Registry Number.

681853-92-9Relevant articles and documents

COMPOUNDS AND METHODS FOR TREATING ADDICTION AND RELATED DISORDERS

-

, (2019/08/29)

The present invention relates to compounds and methods of use thereof for treatment of certain disorders and conditions, for example an addiction or compulsive disorder.

Total syntheses of a conformationally locked North-type methanocarba puromycin analogue and a dinucleotide derivative

Michel, Benoit Y.,Strazewski, Peter

supporting information; experimental part, p. 6244 - 6257 (2010/03/26)

An original synthetic approach for the first synthesis of an enantiopure methanocarba puromycin (3'-α-aminoacylamino-3'-deoxyadenosine) analogue and its cytidine dinucleotide derivative is described. Each compound is conformationally locked in a North-typ

Stereoselective synthesis of 3-hydroxymethyl-D-cyclopentenone, the versatile intermediate for the synthesis of carbocyclic nucleosides

Choi, Won Jun,Moon, Hyung Ryong,Kim, Hea Ok,Ko, Young Mi,Kim, Hye Jin,Lee, Jeong A.,Lee, Kang Man,Yun, Mi Kyung,Shin, Dae Hong,Chun, Moon Woo,Sheen, Yhun Y.,Kim, Kilhyoun,Jeong, Lak Shin

, p. 611 - 613 (2008/02/04)

The preparative and stereoselective synthesis (45-50% overall yields, >50 g scale) of the key carbasugars 7a-d was achieved from D-ribose via stereoselective Grignard reaction and oxidative rearrangement as key reactions. Copyright Taylor & Francis, Inc.

Post a RFQ

Enter 15 to 2000 letters.Word count: 0 letters

Attach files(File Format: Jpeg, Jpg, Gif, Png, PDF, PPT, Zip, Rar,Word or Excel Maximum File Size: 3MB)

1

What can I do for you?
Get Best Price

Get Best Price for 681853-92-9